Clal Biotechnology reported ILS4.44M in Stock for its fiscal quarter ending in March of 2021.





Stock Change Date
aTyr Pharma USD 2.86M 126.59K Sep/2025
Cara Therapeutics USD 900K 0 Mar/2025
Clal Biotechnology ILS 4.44M 0 Mar/2021
Infinity Pharmaceuticals USD 0 0 Sep/2021
RedHill Biopharma USD 3.17M 482K Jun/2025
TherapeuticsMD USD 6.7M 551K Sep/2022